Digital data collection company Research Now Group priced and allocated a package of first- and second-lien loans Wednesday, raising funds to close on its buyout by private equity firm Court Square Partners, according to KDP Investment Advisors.
Valeant Pharmaceuticals on Friday wrapped $14.15 billion in debt funding for its plans to acquire Salix Pharmaceuticals, despite a rival unsolicited bid by Endo International for Salix that surfaced this week.
Endo International confirmed Wednesday it has submitted an unsolicited $15.7 billion takeover bid for Salix Pharmaceuticals. But Valeant Pharmaceuticals said it planned to stay the course with its $14.5 acquisition agreement with Salix, and is moving forward with bond and loan offerings that hit the market this week to finance the merger.
Walgreens Infusion Services, a planned spinoff of the drugstore chains specialty intravenous therapy unit, is launching a $415 million term loan B proposal to fund Madison Dearborn Partners majority stake purchase in the new company.
The loans are part of a $15.15 billion debt commitment Valeant Pharmaceuticals has received for its $14.5 billion proposed takeover of Salix Pharmaceuticals. Valeant also revealed it will also seek $9.6 billion through an unsecured private-sale notes offering.
C&J is holding a lenders meeting Wednesday to discuss terms and commitment dates for the offer, two months after the Delaware Supreme Court reinstated a merger agreement challenged by some of its shareholders.
Proceeds from the bond sale will be combined with a $1.53 billion term loan B and a $100 million revolver to fund the company's buyout.
Consumer packaging supplier Ball Corp. had its ratings placed under review by Moodys Investors Service, and its outlook revised to negative by Standard & Poors, in the wake of its plans to acquire UK-based beverage-can producer Rexam PLC for $8.4 billion including debt.
Moodys Investors Service and Standard & Poors issued comments Friday stating that the existing ratings for the market-leading online travel agency would not be impacted, even if the entire $1.6 billion transaction were to be funded with debt.
Commitments are due today on a $4.3 billion term loan B term loan B buyout proposal from PetSmart, which accelerated the original Feb. 20 deadline by one week, according to reports.